Although monoclonal in origin, mammary tumors acquire a marked heterogeneity of cell phenotypes, including a mixture of steroid hormone-sensitive cells and insensitive cells. We describe here long-term studies on the effects of androgen withdrawal on cloned androgen-responsive $115 mouse mammary tumor cells as a model system to investigate mechanisms by which tumor cells lose their steroid sensitivity. In the prolonged absence of androgen, the cells lost hormone-sensitive parameters reproducibly, including loss of proliferative response, saturation density response, cell morphology response, and mouse mammary tumor virus long terminal repeat (MMTV-LTR)-related RNA. These experiments have demonstrated that when deprived of hormone in the long term, a clone of responsive cells gives rise reproducibly to a population of unresponsive cells in an ordered series of phenotypic changes. At the time when the cells lost all androgen response in terms of cell biology and MMTV-LTR-RNA, increased methylation of MMTV-LTR sequences in the DNA was detected. Thereafter recovery of androgen sensitivity has not been achieved in any of these parameters. The possible role of de novo DNA methylation in the progression to androgen autonomy of $115 cells is discussed.Manipulation of the steroid environment affects breast tumor growth in many species (26, 29) but only on a temporary basis, and even in rodents, where effects are greatest, it never eliminates the tumor completely (19). In man, 30% of breast cancers regress after endocrine therapy, and a recent approach has been to select likely hormone-sensitive tumors on the basis of estrogen and progesterone receptor levels (9). However, possession of receptors is not the sole criterion for response to therapy and in any case regression is at best temporary, to be followed by hormone-independent tumors and metastatic disease. This progression to hormone insensitivity is a major clinical problem.Tumors are composed of mixed populations of cells that have a wide range of phenotypes. Cells obtained from individual rodent mammary tumors differ not only in hormone receptors (35) and hormone-dependent growth (8, 39) but also in immunological properties (24), transplantability (36), metastatic capability (18), tumorigenicity (38), drug resistance (23), growth rate (11), karyotype (11,22), mouse mammary tumor virus (MMTV) 1 expression (35), and MMTV proviral Abbreviations used in this paper. +A and -A, androgen responsive and unresponsive, respectively; DC, dextran-charcoal; DME, Dulbeccopies (32). It is now accepted that the origin of mammary tumors is monoclonal (10), but how such diversity arises is still unknown. The mechanism could involve either genotypic or phenotypic change. Evidence for a genotypic mechanism, involving mutation followed by cell selection, has been implied from karyotype studies (11,22,25) and from changes in exogenous integrated MMTV (32). A phenotypic mechanism would involve stable alteration in the program of gene expression and could result from either sele...